Biomarin Pharmaceuticals (NQ: BMRN )

70.35 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 11, 2024 Add to My Watchlist

Other Filings

Form 8-K
Source: SEC/Edgar
April 24, 2019
Form DEFA14A
Source: SEC/Edgar
April 22, 2019
Form DEF 14A
Source: SEC/Edgar
April 22, 2019
Form 8-K
Source: SEC/Edgar
February 20, 2019
Form SC 13G
Source: SEC/Edgar
February 13, 2019
Form SC 13G/A
Source: SEC/Edgar
February 13, 2019
Form SC 13G/A
Source: SEC/Edgar
February 10, 2019
Form SC 13G/A
Source: SEC/Edgar
February 10, 2019
Form SC 13G/A
Source: SEC/Edgar
February 07, 2019
Form SC 13G/A
Source: SEC/Edgar
January 30, 2019
Form SC 13G/A
Source: SEC/Edgar
January 30, 2019
Form 8-K
Source: SEC/Edgar
January 07, 2019
Form 8-K
Source: SEC/Edgar
October 24, 2018
Form 8-K
Source: SEC/Edgar
October 22, 2018
Form 8-K
Source: SEC/Edgar
September 23, 2018
Form S-8 POS
Source: SEC/Edgar
August 21, 2018
Form S-8 POS
Source: SEC/Edgar
August 21, 2018
Form 8-K
Source: SEC/Edgar
August 01, 2018
Form 8-K
Source: SEC/Edgar
June 07, 2018
Form 8-K
Source: SEC/Edgar
April 24, 2018
Form DEF 14A
Source: SEC/Edgar
April 23, 2018
Form DEFA14A
Source: SEC/Edgar
April 23, 2018
Form SC 13G/A
Source: SEC/Edgar
February 13, 2018
Form SC 13G/A
Source: SEC/Edgar
February 13, 2018
Form SC 13G/A
Source: SEC/Edgar
February 12, 2018
Form SC 13G/A
Source: SEC/Edgar
February 11, 2018
Form CT ORDER
Source: SEC/Edgar
February 11, 2018
Form SC 13G/A
Source: SEC/Edgar
February 07, 2018
Form SC 13G/A
Source: SEC/Edgar
February 04, 2018
Form SC 13G/A
Source: SEC/Edgar
January 25, 2018
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.